Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2570)
All Articles published online
|
Apr 1, 2004 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan GJ, Zhang ML, Gong ZJ. Effects of PPARg agonist pioglitazone on rat hepatic fibrosis. World J Gastroenterol 2004; 10(7): 1047-1051 [PMID: 15052691 DOI: 10.3748/wjg.v10.i7.1047] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v10/i7/1047.htm |
| Number | Citing Articles |
| 1 |
Anurag Maheshwari, Warren Maley, Zhiping Li, Paul J. Thuluvath. Biliary complications and outcomes of liver transplantation from donors after cardiac death. Liver Transplantation 2007; 13(12): 1645 doi: 10.1002/lt.21212
|
| 2 |
Rasha R. Radwan, Hesham F. Hasan. Pioglitazone ameliorates hepatic damage in irradiated ratsviaregulating anti-inflammatory and antifibrogenic signalling pathways. Free Radical Research 2019; 53(7): 748 doi: 10.1080/10715762.2019.1624742
|
| 3 |
Esraa M. Zakariaª, Rasha H. Abdel-Ghanyª, Atef S. Elgharbawyª, Amira Ebrahim Alsemehᵇ, Sami S. Metwallyª. A novel approach to repositioning memantine for metabolic syndrome-induced steatohepatitis: Modulation of hepatic autophagy, inflammation, and fibrosis. Life Sciences 2023; 319: 121509 doi: 10.1016/j.lfs.2023.121509
|
| 4 |
A. J. Demetris, Paulo Fontes, John G. Lunz, Susan Specht, Noriko Murase, Amadeo Marcos. Wound Healing in the Biliary Tree of Liver Allografts. Cell Transplantation 2006; 15(1_suppl): 57 doi: 10.3727/000000006783982386
|
| 5 |
Kaveh Baghaei, Sogol Mazhari, Samaneh Tokhanbigli, Gilda Parsamanesh, Helia Alavifard, Dedmer Schaafsma, Saeid Ghavami. Therapeutic potential of targeting regulatory mechanisms of hepatic stellate cell activation in liver fibrosis. Drug Discovery Today 2022; 27(4): 1044 doi: 10.1016/j.drudis.2021.12.012
|
| 6 |
L A Adams, P Angulo. Treatment of non-alcoholic fatty liver disease. Postgraduate Medical Journal 2006; 82(967): 315 doi: 10.1136/pgmj.2005.042200
|
| 7 |
Devaraj Ezhilarasan, Sivanesan Karthikeyan, Palani Vivekanandan. Ameliorative effect of silibinin against N-nitrosodimethylamine-induced hepatic fibrosis in rats. Environmental Toxicology and Pharmacology 2012; 34(3): 1004 doi: 10.1016/j.etap.2012.07.004
|
| 8 |
Brittany B. Dennis, Sandy Sallam, Brandon J. Perumpail, Neha D. Shah, Donghee Kim, George Cholankeril, Aijaz Ahmed. Management of Cardiometabolic Complications in Patients With Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology 2021; 55(9): 747 doi: 10.1097/MCG.0000000000001555
|
| 9 |
Salwa A. Ibrahim, Mervat Z. Mohamed, Nashwa F. El-Tahawy, Aly M. Abdelrahman. Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. Canadian Journal of Physiology and Pharmacology 2021; 99(3): 313 doi: 10.1139/cjpp-2020-0159
|
| 10 |
Ana Thereza B. Gomes, Carla Guimarães Bastos, Clara L. Afonso, Bruno Frederico Medrado, Zilton A. Andrade. How variable are hydroxyproline determinations made in different samples of the same liver?. Clinical Biochemistry 2006; 39(12): 1160 doi: 10.1016/j.clinbiochem.2006.08.002
|
| 11 |
Patricia J. Sime, R. Matthew Kottmann, Heather F. Lakatos, Thomas H. Thatcher. Transforming Growth Factor-β in Cancer Therapy, Volume I. 2008; : 629 doi: 10.1007/978-1-59745-292-2_40
|
| 12 |
Nikhat J. Siddiqi, Seema Zargar. Effect of quercetin on cadmium fluoride-induced alterations in hydroxyproline/collagen content in mice liver. Connective Tissue Research 2014; 55(3): 234 doi: 10.3109/03008207.2014.900551
|
| 13 |
Silvia Berardis, Prenali Dwisthi Sattwika, Mustapha Najimi, Etienne Marc Sokal. Use of mesenchymal stem cells to treat liver fibrosis: Current situation and future prospects. World Journal of Gastroenterology 2015; 21(3): 742-758 doi: 10.3748/wjg.v21.i3.742
|
| 14 |
Makoto Higashimaya, Shiro Oka, Shinji Tanaka, Yoji Sanomura, Shigeto Yoshida, Toru Hiyama, Koji Arihiro, Fumio Shimamoto, Kazuaki Chayama. Outcome of endoscopic submucosal dissection for gastric neoplasm in relationship to endoscopic classification of submucosal fibrosis. Gastric Cancer 2013; 16(3): 404 doi: 10.1007/s10120-012-0203-0
|
| 15 |
Kenneth Cusi. Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications. Gastroenterology 2012; 142(4): 711 doi: 10.1053/j.gastro.2012.02.003
|
| 16 |
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC. International Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
|
| 17 |
Erica Vetrano, Luca Rinaldi, Andrea Mormone, Chiara Giorgione, Raffaele Galiero, Alfredo Caturano, Riccardo Nevola, Raffaele Marfella, Ferdinando Carlo Sasso. Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies. Biomedicines 2023; 11(2): 468 doi: 10.3390/biomedicines11020468
|
| 18 |
Baixue Zheng, Looling Tan, Xuejun Mo, Weimiao Yu, Yan Wang, Lisa Tucker-Kellogg, Roy E. Welsch, Peter T. C. So, Hanry Yu, Maria A. Deli. Predicting In Vivo Anti-Hepatofibrotic Drug Efficacy Based on In Vitro High-Content Analysis. PLoS ONE 2011; 6(11): e26230 doi: 10.1371/journal.pone.0026230
|
| 19 |
Feng Zhang, Desong Kong, Yin Lu, Shizhong Zheng. Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside. Cellular and Molecular Life Sciences 2013; 70(2): 259 doi: 10.1007/s00018-012-1046-x
|
| 20 |
Alessandro Federico, Marco Niosi, Camillo Del Vecchio Blanco, Carmela Loguercio. Emerging drugs for non-alcoholic fatty liver disease. Expert Opinion on Emerging Drugs 2008; 13(1): 145 doi: 10.1517/14728214.13.1.145
|
| 21 |
Tao Wei, Andrew G Geiser, Hui-Rong Qian, Chen Su, Leah M Helvering, Nalini H Kulkarini, Jianyong Shou, Mathias N'Cho, Henry U Bryant, Jude E Onyia. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Women's Health 2007; 7(1) doi: 10.1186/1472-6874-7-5
|
| 22 |
Belinda Knight, Bu B. Yeap, George C. Yeoh, John K. Olynyk. Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member γ, but not α or δ. Carcinogenesis 2005; 26(10): 1782 doi: 10.1093/carcin/bgi138
|
| 23 |
A J Demetris, John G Lunz III, Susan Specht, Isao Nozaki. Biliary wound healing, ductular reactions, and IL-6/gp130 signaling in the development of liver disease. World Journal of Gastroenterology 2006; 12(22): 3512-3522 doi: 10.3748/wjg.v12.i22.3512
|
| 24 |
|
| 25 |
Weiwei Shan, Christopher J. Nicol, Shinji Ito, Moses T. Bility, Mary J. Kennett, Jerrold M. Ward, Frank J. Gonzalez, Jeffrey M. Peters. Peroxisome proliferator-activated receptor-β/δ protects against chemically induced liver toxicity in mice. Hepatology 2007; 47(1): 225 doi: 10.1002/hep.21925
|
| 26 |
Leila Moezi, Reza Heidari, Zahra Amirghofran, Ali Akbar Nekooeian, Ahmad Monabati, Ahmad R. Dehpour. Enhanced anti-ulcer effect of pioglitazone on gastric ulcers in cirrhotic rats: The role of nitric oxide and IL-1β. Pharmacological Reports 2013; 65(1): 134 doi: 10.1016/S1734-1140(13)70971-X
|
| 27 |
Heung-Man Lee, Hee Jun Kang, Hyo Hun Park, Seok-Chan Hong, Jin-Kook Kim, Jae Hoon Cho. Effect of Peroxisome Proliferator—Activated Receptor Gamma Agonists on Myofibroblast Differentiation and Collagen Production in Nasal Polyp—Derived Fibroblasts. Annals of Otology, Rhinology & Laryngology 2009; 118(10): 721 doi: 10.1177/000348940911801007
|
| 28 |
Ningning Yang, Gaoxiang Yu, Yingying Lai, Jiayi Zhao, Zhuliu Chen, Liang Chen, Yuedong Fu, Pin Fang, Weiyang Gao, Yuepiao Cai, Zhijie Li, Jian Xiao, Kailiang Zhou, Jian Ding. A snake cathelicidin enhances transcription factor EB‐mediated autophagy and alleviates ROS‐induced pyroptosis after ischaemia–reperfusion injury of island skin flaps. British Journal of Pharmacology 2024; 181(7): 1068 doi: 10.1111/bph.16268
|
| 29 |
Yun-Xia LUO, Xin-Yue WANG, Yu-Jie HUANG, Shu-Huan FANG, Jun WU, Yong-Bin ZHANG, Tian-Qin XIONG, Cong YANG, Jian-Gang SHEN, Chuan-Lan SANG, Qi WANG, Jian-Song FANG. Systems pharmacology-based investigation of Sanwei Ganjiang Prescription: related mechanisms in liver injury. Chinese Journal of Natural Medicines 2018; 16(10): 756 doi: 10.1016/S1875-5364(18)30115-8
|
| 30 |
Sherehan M. Ibrahim, Ezzedin S. El- Denshary, Dalaal M. Abdallah, Marta Letizia Hribal. Geraniol, Alone and in Combination with Pioglitazone, Ameliorates Fructose-Induced Metabolic Syndrome in Rats via the Modulation of Both Inflammatory and Oxidative Stress Status. PLOS ONE 2015; 10(2): e0117516 doi: 10.1371/journal.pone.0117516
|
| 31 |
Radina Kostadinova, Alexandra Montagner, Erwan Gouranton, Sébastien Fleury, Hervé Guillou, David Dombrowicz, Pierre Desreumaux, Walter Wahli. GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation. Cell & Bioscience 2012; 2(1) doi: 10.1186/2045-3701-2-34
|
| 32 |
Xianzhi Liu, Lifu Wang, Siwei Tan, Zebin Chen, Bin Wu, Xiaoying Wu. Therapeutic Effects of Berberine on Liver Fibrosis are associated With Lipid Metabolism and Intestinal Flora. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.814871
|